AU2002341901A1 - Novel compositions of carvedilol - Google Patents
Novel compositions of carvedilolInfo
- Publication number
- AU2002341901A1 AU2002341901A1 AU2002341901A AU2002341901A AU2002341901A1 AU 2002341901 A1 AU2002341901 A1 AU 2002341901A1 AU 2002341901 A AU2002341901 A AU 2002341901A AU 2002341901 A AU2002341901 A AU 2002341901A AU 2002341901 A1 AU2002341901 A1 AU 2002341901A1
- Authority
- AU
- Australia
- Prior art keywords
- carvedilol
- novel compositions
- compositions
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- NPAKNKYSJIDKMW-UHFFFAOYSA-N carvedilol Chemical group COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=NC3=CC=C[CH]C3=C12 NPAKNKYSJIDKMW-UHFFFAOYSA-N 0.000 title 1
- 229960004195 carvedilol Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32636701P | 2001-10-01 | 2001-10-01 | |
| US60/326,367 | 2001-10-01 | ||
| US33023401P | 2001-10-18 | 2001-10-18 | |
| US60/330,234 | 2001-10-18 | ||
| PCT/US2002/031123 WO2003028645A2 (fr) | 2001-10-01 | 2002-10-01 | Nouvelles compositions de carvedilol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002341901A1 true AU2002341901A1 (en) | 2003-04-14 |
Family
ID=26985374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002341901A Abandoned AU2002341901A1 (en) | 2001-10-01 | 2002-10-01 | Novel compositions of carvedilol |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002341901A1 (fr) |
| WO (1) | WO2003028645A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2492060C (fr) | 2002-06-27 | 2011-11-01 | Sb Pharmco Puerto Rico Inc. | Sels de phospate de carvedilol et/ou solvates de celui-ci, compositions et/ou methodes de traitement associees |
| AU2003251627A1 (en) | 2002-06-27 | 2004-01-19 | Sb Pharmco Puerto Rico Inc. | Carvedilol hydrobromide |
| JP2007512372A (ja) | 2003-11-25 | 2007-05-17 | エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド | カルベジロール塩、対応する組成物、送達および／または治療方法 |
| US9149433B2 (en) * | 2004-11-30 | 2015-10-06 | Basf Corporation | Method for formation of micro-prilled polymers |
| US20080138404A1 (en) * | 2006-12-06 | 2008-06-12 | Biovail Laboratories International S.R.L. | Extended release formulations of carvedilol |
| TW202448511A (zh) * | 2023-05-11 | 2024-12-16 | 英商康泰倫特英國斯文敦載迪斯有限公司 | 增加活性醫藥成分之胃前吸收的滲透性 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19637082A1 (de) * | 1996-09-12 | 1998-03-19 | Boehringer Mannheim Gmbh | Schnellzerfallende Pellets |
| US6395300B1 (en) * | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
-
2002
- 2002-10-01 AU AU2002341901A patent/AU2002341901A1/en not_active Abandoned
- 2002-10-01 WO PCT/US2002/031123 patent/WO2003028645A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003028645A2 (fr) | 2003-04-10 |
| WO2003028645A3 (fr) | 2004-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002363005A1 (en) | Derivatives of uk-2a | |
| AU2002332019A1 (en) | Adjuvant compositions | |
| AU2001297631A1 (en) | Novel formulations of carvedilol | |
| AU2002361149A1 (en) | Set of teeth | |
| AU2002241114A1 (en) | Composition | |
| AU2002365093A1 (en) | Therapeutic compositions | |
| AU2002341924A1 (en) | Novel composition of carvedilol | |
| AU2002321808A1 (en) | Dental compositions | |
| AUPR600601A0 (en) | Therapeutic compositions | |
| AU2002356615A1 (en) | Novel utilization of cyclopentabenzofurans | |
| AU2002341901A1 (en) | Novel compositions of carvedilol | |
| AUPR446801A0 (en) | Novel compositions and uses therefor | |
| AU2002360974A1 (en) | Novel use of alloys | |
| AU2003298725A1 (en) | Preparation of metallotexaphyrins | |
| AU2002341923A1 (en) | Novel formulations of carvedilol | |
| AU2002359898A1 (en) | Preparation of alpha-diimines | |
| AU2002232061A1 (en) | Compositions having improved bioavailability of eletriptan | |
| AUPR795301A0 (en) | Novel compositions | |
| AU2002230229A1 (en) | Novel ophthalmic compositions | |
| AU2002255261A1 (en) | Novel use of arylethenessulfonamide derivatives | |
| AU2001288046A1 (en) | Novel use of tricyclic compound | |
| AU2002300773A1 (en) | Preparation of Dialkylpyridylboranes | |
| AU2002338934A1 (en) | Preparation of benzosuberonylpiperidine compounds | |
| AU2002315611A1 (en) | Fabric-cleaning compositions | |
| AUPR971001A0 (en) | Compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |